Martinucci I, Natilli M, Lorenzoni V, Pappalardo L, Monreale A, Turchetti G, et al. Gastroesophageal reflux symptoms among Italian university students: epidemiology and dietary correlates using automatically recorded transactions. BMC Gastroenterol. 2018;18(1):116.

Article  PubMed  PubMed Central  Google Scholar 

Pacini F, Calabrese C, Cipolletta L, Valva MD, Russo A, Savarino V, et al. Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin. 2005;21(4):495–502.

Article  PubMed  Google Scholar 

GBD 2017 Gastro-oesophageal Reflux Disease Collaborators. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):561-81.

Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, Ayazi A, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13(8):1440–7.

Article  PubMed  PubMed Central  Google Scholar 

Bredenoord AJ, Pandolfino JE, Smout AJ. Gastro-oesophageal reflux disease. Lancet. 2013;381(9881):1933–42.

Article  PubMed  Google Scholar 

El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5(1):17–26.

Article  PubMed  Google Scholar 

El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.

Article  PubMed  Google Scholar 

Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8(6):340–7.

Article  PubMed  Google Scholar 

Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61(10):1390–7.

Article  PubMed  Google Scholar 

Bert F, Pompili E, Lo Moro G, Corradi A, Sagrawa Caro A, Gualano MR, et al. Prevalence of gastro-oesophageal reflux symptoms: an Italian cross-sectional survey focusing on knowledge and attitudes towards lifestyle and nutrition. Int J Clin Pract. 2021;75(3): e13758.

Article  PubMed  Google Scholar 

Darbà J, Kaskens L, Plans P, Elizalde JI, Coma M, Cuomo R, et al. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett’s syndrome in Germany, Italy and Spain. Expert Rev Pharmacoecon Outcomes Res. 2011;11(2):225–32.

Article  PubMed  Google Scholar 

King A, MacDonald C, Orn C. Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int J Clin Pract. 2008;62(12):1838–43.

Article  CAS  PubMed  Google Scholar 

National Institute for Health and Care Excellence. Clinical guideline [CG184]: Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. London: National Institute for Health and Care Excellence (NICE); 2019.

Google Scholar 

Bjelović M, Harsányi L, Altorjay Á, Kincses Z, Forsell P. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark. BMC Surg. 2020;20(1):159.

Article  PubMed  PubMed Central  Google Scholar 

Implantica. Implantica receives CE Mark Approval for RefluxStop, a potential Paradigm shift in the Treatment for Acid reflux. [Available from: https://www.implantica.com/media/press-releases/2018/implantica-receives-ce-mark-approval-for-refluxstop-a-potential-paradigm-shift-in-the-treatment-for-acid-reflux/.

Harper S, Grodzicki L, Mealing S, Gemmill L, Goldsmith PJ, Ahmed AR. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. J Med Econ. 2023;26(1):603–13.

Article  PubMed  Google Scholar 

Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17(1):5–14.

Article  PubMed  Google Scholar 

Brosa M, Gisbert R, Rodríguez Barrios J, Soto J. Principios, métodos y aplicaciones del análisis del impacto presupuestario en sanidad. Span Res Articles. 2005;2:65–79.

Google Scholar 

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.

Article  PubMed  Google Scholar 

Istat Statistics [Available from: http://dati.istat.it/.

Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354–9.

Article  CAS  PubMed  Google Scholar 

Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

NHS Dorset Clinical Commissioning Group. In Focus: High-Cost PPIs [Available from: https://www.dorsetccg.nhs.uk/Downloads/aboutus/medicines-management/Other%20Guidelines/Gastroenterology%20High%20cost%20PPI%20in%20focus%200519%20%282%29.pdf?UNLID=97481392021984165.

Weickum J, Higgins A, Wright G, Qadeer R, Ferko N. PGI11 A budget impact model for medication refractory gastroesophageal reflux disease pateints treated with laparoscopic nissen fundoplication or magnetic sphincter augmentation: an Italian payer perspective. Value Health. 2019;22:S618.

Article  Google Scholar 

Shemilt I, Thomas J, Morciano M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6:51–60.

Article  Google Scholar 

Nochaiwong S, Ruengorn C, Awiphan R, Koyratkoson K, Chaisai C, Noppakun K, et al. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018;33(2):331–42.

Article  CAS  PubMed  Google Scholar 

Batchelor R, Kumar R, Gilmartin-Thomas JFM, Hopper I, Kemp W, Liew D. Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel. Aliment Pharmacol Ther. 2018;48(8):780–96.

Article  CAS  PubMed  Google Scholar 

Nassar Y, Richter S. Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis. J Bone Metab. 2018;25(3):141–51.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen PA, Islam M, Galvin CJ, Chang CC, An SY, Yang HC, et al. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia. Int J Qual Health Care. 2020;32(5):292–9.

Article  PubMed  Google Scholar 

Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poly TN, Lin MC, Syed-Abdul S, Huang CW, Yang HC, Li YJ. Proton pump inhibitor use and risk of gastric cancer: current evidence from epidemiological studies and critical appraisal. Cancers (Basel). 2022;14(13):5.

Article  Google Scholar 

Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci. 2020;1481(1):117–26.

Article  CAS  PubMed  Google Scholar 

Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil. 2018;24(4):559–69.

Article  PubMed  PubMed Central  Google Scholar 

Scarpignato C, Gatta L, Zullo A, Blandizzi C. Effective and safe proton pump inhibitor therapy in acid-related diseases—A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14(1):179.

Article  PubMed  PubMed Central  Google Scholar 

Rettura F, Bronzini F, Campigotto M, Lambiase C, Pancetti A, Berti G, et al. Refractory gastroesophageal reflux disease: a management update. Front Med (Lausanne). 2021;8: 765061.

Article  PubMed  PubMed Central  Google Scholar 

Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015;2015(11):3243.